Intermolecular

Intermolecular is a leading source for advanced materials discovery and understanding. We work closely with our customers using our High Productivity Combinatorial™(HPC) platform to discover, develop and characterize engineered materials for next generation high-technology products. Good decisions require good data, and that’s where Intermolecular gives its partners a powerful competitive advantage – by generating high quality and extensive experimental data in less time. Intermolecular's solutions and services create value for its customers by enabling them to rapidly discover and create new options for mission-critical materials decisions.
Company Growth (employees)
Type
Public
HQ
San Jose, US
Founded
2004
Size (employees)
145 (est)-17%
Intermolecular was founded in 2004 and is headquartered in San Jose, US

Key People at Intermolecular

Tony Chiang, Ph.D

Tony Chiang, Ph.D

CTO

Intermolecular Office Locations

Intermolecular has an office in San Jose
San Jose, US (HQ)
3011 N 1st St

Intermolecular Metrics

Intermolecular Financial Metrics

Revenue (2016)

$47.3 m

Revenue growth (2015-16), %

4%

Gross profit

$31.5 m

Gross profit margin (2016), %

67%

Net income (2016)

($15.4 m)

Market capitalization (28-Apr-2017)

$40.1 m

Closing share price (28-Apr-2017)

$0.8

Cash (31-Dec-2016)

$5.8 m
Intermolecular's current market capitalization is $40.1 m.
Intermolecular's revenue was reported to be $47.3 m in FY, 2016 which is a 4% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$67.4 m$47.7 m$45.3 m$47.3 m

Revenue growth, %

(29%)(5%)4%

Cost of goods sold

$32.5 m$24.7 m$19.3 m$15.8 m

Gross profit

$34.9 m$23 m$26 m$31.5 m

Gross profit Margin, %

52%48%57%67%

Operating expense total

$43 m$44.1 m$46.7 m$47.3 m

EBIT

($8 m)($21 m)($20.7 m)($15.9 m)

EBIT margin, %

(12%)(44%)(46%)(34%)

Interest expense

$830 k$682 k$267 k$173 k

Interest income

$173 k

Pre tax profit

($8.8 m)($21.8 m)($21 m)($15.4 m)

Income tax expense

$17 k$7 k$8 k$7 k

Net Income

($8.8 m)($21.8 m)($21 m)($15.4 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$72.1 m$21.8 m$11.7 m$5.8 m

Accounts Receivable

Inventories

$2.2 m$1.8 m$1.6 m$1.4 m

Current Assets

$81.4 m$72.2 m$43.1 m$32.3 m

PP&E

$28.5 m$19.1 m$15.7 m$11 m

Total Assets

$124.5 m$105.4 m$69.7 m$53.2 m

Accounts Payable

$2.2 m$862 k$848 k$309 k

Current Liabilities

$14 m$10.1 m$10.2 m$5 m

Additional Paid-in Capital

$194.9 m$202.1 m$209 m$213.3 m

Retained Earnings

($110.1 m)($131.9 m)($152.9 m)($168.3 m)

Total Equity

$56.1 m$45 m

Financial Leverage

1.2 x1.2 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($8.8 m)($21.8 m)($21 m)($15.4 m)

Depreciation and Amortization

$10.9 m

Accounts Receivable

$1.7 m$1.1 m

Inventories

$2.2 m$1.6 m$1.6 m

Accounts Payable

$2.2 m($635 k)$848 k($493 k)

Cash From Operating Activities

($6.2 m)($1.9 m)($10.1 m)($5.4 m)

Purchases of PP&E

($2.8 m)($2.4 m)

Cash From Investing Activities

($47.7 m)($1.2 m)

Cash From Financing Activities

($810 k)$701 k

Interest Paid

$666 k$9 k

Intermolecular Market Value History

Intermolecular Median Salaries

Source: 17 public H-1B filings from Intermolecular

Intermolecular Company Life

You may also be interested in